Literature DB >> 31537479

Antibiograms Cannot Be Used Interchangeably Between Acute Care Medical Centers and Affiliated Nursing Homes.

Maria-Stephanie A Hughes1, David M Dosa2, Aisling R Caffrey2, Haley J Appaneal2, Robin L P Jump3, Vrishali Lopes4, Kerry L LaPlante5.   

Abstract

OBJECTIVE: To determine whether antibiograms for Veterans Affairs (VA) nursing homes (NHs), termed Community Living Centers, are similar to those from their affiliated acute care medical centers.
DESIGN: Descriptive study. SETTING AND PARTICIPANTS: We compared the 2017 antibiograms for VA NHs to their affiliated VA medical centers (VAMCs). Antibiograms included antibiotic susceptibility rates for commonly observed bacteria in this setting (Staphylococcus aureus, Enterococcus spp, Escherichia coli, Klebsiella spp, Proteus mirabilis, and Pseudomonas aeruginosa).
METHODS: Antibiograms were considered to be in complete agreement when the overall susceptibility rate between the NH and affiliated VAMC was either at or above 80% or below 80% across all bacteria and antibiotics. Average percentage of bacteria-antibiotic comparisons in disagreement per facility pair, and number of facilities with agreement for specific bacteria-antibiotic comparisons were also assessed. The chi-square test was used to compare disagreement between NH-VAMC facilities based on geographic proximity of the NH to the VAMC, culture source, and bed size.
RESULTS: A total of 119 NH-VAMC affiliate pairs were included in this analysis, with 71% (84/119) on the same campus and 29% (35/119) on geographically distinct campuses. None of the NH-VAMC pairs demonstrated complete agreement (all bacteria vs all antibiotics) between their antibiograms. On average, 20% of the bacteria-antibiotic comparisons from the antibiogram disagreed clinically per NH-VAMC pair, and almost twice as often the nursing home had lower susceptibility (higher resistance) than the acute care facility. Some bacteria-antibiotic comparisons agreed in all facilities (eg, E coli-imipenem; S aureus-linezolid; S aureus-vancomycin), while others showed greater disagreement (eg, Klebsiella spp-cefazolin; Klebsiella spp-ampicillin-sulbactam; P aeruginosa-ciprofloxacin). Rates of clinical disagreement were similar by geographic proximity of the NH to the VAMC, culture source, and bed size. CONCLUSIONS AND IMPLICATIONS: Overall, this study showed a moderate lack of agreement between VA NH antibiograms and their affiliate VAMC antibiograms. Our data suggest that antibiograms of acute care facilities are often not accurate approximations of the nursing home resistance patterns and therefore should be used with caution (if at all) in guiding empiric antibiotic therapy. Published by Elsevier Inc.

Entities:  

Keywords:  Antibiogram; Community Living Center; Veterans Affairs; antimicrobial stewardship; empiric antibiotic therapy

Mesh:

Substances:

Year:  2019        PMID: 31537479      PMCID: PMC7233453          DOI: 10.1016/j.jamda.2019.07.016

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  25 in total

1.  Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey.

Authors:  Katrien Latour; Boudewijn Catry; Elisabeth Broex; Vanessa Vankerckhoven; Arno Muller; Rudi Stroobants; Herman Goossens; Béatrice Jans
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01-24       Impact factor: 2.890

2.  Antibiotic use in long-term care facilities.

Authors:  Nick Daneman; Andrea Gruneir; Alice Newman; Hadas D Fischer; Susan E Bronskill; Paula A Rochon; Geoff M Anderson; Chaim M Bell
Journal:  J Antimicrob Chemother       Date:  2011-09-27       Impact factor: 5.790

Review 3.  Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute.

Authors:  Janet F Hindler; John Stelling
Journal:  Clin Infect Dis       Date:  2007-02-08       Impact factor: 9.079

4.  The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.

Authors:  Amy L Pakyz
Journal:  Pharmacotherapy       Date:  2007-09       Impact factor: 4.705

Review 5.  Antibiotic use and resistance in long term care facilities.

Authors:  Laura W van Buul; Jenny T van der Steen; Ruth B Veenhuizen; Wilco P Achterberg; François G Schellevis; Rob T G M Essink; Birgit H B van Benthem; Stephanie Natsch; Cees M P M Hertogh
Journal:  J Am Med Dir Assoc       Date:  2012-05-09       Impact factor: 4.669

6.  Emergency Department Urinary Antibiograms Differ by Specific Patient Group.

Authors:  S Jorgensen; M Zurayk; S Yeung; J Terry; M Dunn; P Nieberg; A Wong-Beringer
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

7.  Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients.

Authors:  C Xie; D McD Taylor; B P Howden; P G P Charles
Journal:  Intern Med J       Date:  2012-07       Impact factor: 2.048

Review 8.  Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.

Authors:  Michael N Dudley; Paul G Ambrose; Sujata M Bhavnani; William A Craig; Mary Jane Ferraro; Ronald N Jones
Journal:  Clin Infect Dis       Date:  2013-01-18       Impact factor: 9.079

9.  Comparison of Hospitalwide and Custom Antibiograms for Clinical Isolates of Pseudomonas aeruginosa.

Authors:  John A Bosso; Adam Sieg; Patrick D Mauldin
Journal:  Hosp Pharm       Date:  2013-04

Review 10.  Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives.

Authors:  Ching Jou Lim; David C M Kong; Rhonda L Stuart
Journal:  Clin Interv Aging       Date:  2014-01-13       Impact factor: 4.458

View more
  1 in total

1.  Creation of State Antibiogram and Subsequent Launch of Public Health-Coordinated Antibiotic Stewardship in New Hampshire: Small State, Big Collaboration.

Authors:  Hannah M Leeman; Benjamin P Chan; Carly R Zimmermann; Elizabeth A Talbot; Michael S Calderwood; Apara R Dave; Paul Santos; Katrina E Hansen
Journal:  Public Health Rep       Date:  2021-03-05       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.